4th Jun 2019 07:00
RNS Number : 9079A
Immupharma PLC
04 June 2019
4 JUNE 2019
ImmuPharma PLC
("ImmuPharma" or the "Company")
Notice of AGM and posting of Report & Accounts
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2018, and the Notice of Annual General Meeting has been posted to shareholders.
These documents are available, in electronic form, for download on the Company's website www.immupharma.co.uk.
ImmuPharma's Annual General Meeting will be held on Thursday 27 June at 10:30am (BST) at the offices of: Capital Access Group, 107 Cheapside, London, EC2V 6DN.
For further information please contact: ImmuPharma PLC (www.immupharma.com) | + 44 (0) 207 152 4080 | Tim McCarthy, Chairman Dimitri Dimitriou, Chief Executive Officer | | Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 | SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson | +44 (0) 203 368 8974 +44 (0) 203 815 8880 +44 (0) 1483 413500 | | | | |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DOCUORWRKOANRRR
Related Shares:
Immupharma
